Navigation Links
Transplant drug stimulates immune memory
Date:6/21/2009

splant, Araki notes. That difference may have helped him recognize rapamycin's effects, he says.

Also, rapamycin's effects depend on the dose -- too high a dose will inhibit all T cells without regard to what type they are, he says.

Araki and Ahmed teamed up with Christian Larsen, MD, PhD, director of the Emory Transplant Center and chair of the Department of Surgery, to show that rapamycin had similar effects in rhesus macaques infected with vaccinia virus as in mice. That research was conducted at Emory's Yerkes National Primate Research Center.

Rapamycin, also called sirolimus, was approved by the FDA in 1999 for use after kidney transplants. It was discovered in a soil sample from Easter Island, whose Polynesian name is Rapa Nui.

Transplant patients usually don't take rapamycin by itself, so rapamycin's paradoxical effects may have been masked by other drugs, Larsen says.

For transplant patients, memory T cells can play a role in graft rejection, but they can also protect against infections.

"We are appreciating more and more that memory T cells respond differently to interventions than nave T cells and we have to pay close attention to the situation of the individual patient," Larsen says.

Scientists at the Emory Vaccine Center continue to study how T cells decide whether to become memory cells, because of their importance in maintaining the immune response against chronic infections such as HIV and hepatitis C.

The effects of rapamycin were seen even if Araki gave animals rapamycin only for a week after the infection began, suggesting that the beginning of the infection was when T cells were deciding whether or not to become memory cells.

By using an inhibitory technique (RNA interference) on the genes known to be targeted by rapamycin, Araki was able to show that rapamycin is acting on the CD8 T cells and not on other cells with which they interact.


'/>"/>

Contact: Holly Korschun
404-727-3990
Emory University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Preclinical study suggests organ-transplant drug may aid in lupus fight
2. Study provides hope that some transplant patients could live free of antirejection drugs
3. Study provides hope that some transplant patients could live free of anti-rejection drugs
4. Advanced Age No Bar to Liver Transplant
5. Circulating fats kill transplanted pancreas cells, study shows
6. Sexual function affected by stem cell transplant according to long-term study
7. Dallas-Area Transplant Meeting Puts Spotlight on Key Issues
8. American Society of Transplantations Past President Testifies Before Congress at Forum on Organ Donation
9. Scientists Spot Key to Kidney Transplant Success
10. Fetal cell transplant could be a hidden link between childbirth and reduced risk of breast cancer
11. Patients over age 60 do well after liver transplantation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... of clinical trial participation in the largest ongoing observational ... are not representative of the larger patient base, according ... Dr. Jay Udell. The study authors call into question ... population, and suggest the use of broader enrollment criteria ... "We know that clinical trials can be tremendously expensive ...
(Date:8/27/2014)... Los Angeles, CA (PRWEB) August 27, 2014 ... everyone. To do this, Jaha invested in creating the industry’s ... motivation by adding functions that no other apps possess. ... with a tracker that differentiates in three simple steps: locate, ... will launch on Tuesday, Aug 26, 2014 to garner support ...
(Date:8/27/2014)... 2014 The Global and China Maleic ... the current state of the Maleic Anhydride industry in ... overview of the industry, including definitions, applications and industry ... analysis are provided with a focus on history, developments, ... between the international and Chinese situation is also offered. ...
(Date:8/27/2014)... Do brands know what consumers think of their marketing ... on the topic Sept. 16 when it reveals the results ... Association and the Association of National Advertisers . ... learn what types of marketing messages are the most likable ... decision. While the survey focuses on consumer reaction to radio ...
(Date:8/27/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... PRODUCTS , the global market for advanced orthopedic technology ... to $42.2 billion by 2019, with a compound annual ... New technologies and an increasingly older population are two ... While there are many conventional and generally less expensive ...
Breaking Medicine News(10 mins):Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 3Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 4Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 5Health News:CRN Set To Release Poll Results On What Marketing Tactics Prompt Consumers To Buy 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 3
... say the autism rate in the U.S. is now 1 in ... country know those statistics are inaccurate. , Misdiagnosis is the hottest ... misdiagnosed with autism , a label parents are often pushed ... October 9-11, in 90+ cities around the world, parents will gather ...
... 2009 Golden Apple Awards , CHICAGO, Oct. ... state and local dental societies across the nation with the ... in its 21st year, recognizes outstanding achievement in dental society ... Apple Awards will be presented through the end of the ...
... at Fred Hutchinson Cancer Research Center, Group Health ... of Public Health and Pharmacy have been selected ... million in federal stimulus funding for comparative-effectiveness research ... national hub for conducting such research, which aims ...
... National Institutes of Health announced today a second phase ... funds for 19 research consortia. The Rare Diseases Clinical ... will be awarded a total of just over $117 ... with the new funding will explore the natural history, ...
... widely used for applications that include inventory management, ... luggage security. More recently, these systems have found ... equipment assets and staff members. However, there ... which manufacturers of RFID equipment or medical devices ...
... College of Preventive Medicine (ACPM) supports the recommendations of ... care providers should screen all adults for depression, and ... systems in place to ensure the accurate diagnosis and ... opportunities to identify depression are in the clinics of ...
Cached Medicine News:Health News:Autism Stats Exaggerated: Parents Pushing Back This Weekend 2Health News:ADA Honors State and Local Dental Societies for Their Outreach Programs 2Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 2Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 3Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 4Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 5Health News:NIH announces expansion of Rare Diseases Clinical Research Network 2Health News:NIH announces expansion of Rare Diseases Clinical Research Network 3Health News:NIH announces expansion of Rare Diseases Clinical Research Network 4Health News:NIH announces expansion of Rare Diseases Clinical Research Network 5Health News:NIH announces expansion of Rare Diseases Clinical Research Network 6Health News:NIH announces expansion of Rare Diseases Clinical Research Network 7Health News:NIH announces expansion of Rare Diseases Clinical Research Network 8Health News:GTRI is developing protocols for testing effects of RFID systems on medical devices 2Health News:GTRI is developing protocols for testing effects of RFID systems on medical devices 3
(Date:8/27/2014)... 27, 2014 Sinovac Biotech Ltd. (NASDAQ: SVA ... , today announced the results of the Company,s 2014 Annual ... Beijing , PRC. The required quorum, a majority ... The Company,s shareholders approved the following proposals:  , ... , Simon Anderson , Kenneth Lee and ...
(Date:8/27/2014)... , Aug. 27, 2014  AcelRx Pharmaceuticals, Inc. ... focused on the development and commercialization of innovative therapies ... announced that senior management will be participating at the ... the Morgan Stanley Global Healthcare Conference.  Details of the ... One on One Conference Date: Wednesday September 3 rd ...
(Date:8/26/2014)... KUALA LUMPUR, Malaysia , Aug. 27, 2014 ... penetration of health insurance are fuelling the demand ... . With the rise of medical tourism, the ... is further increasing. The market will continue its ... increasingly vulnerable to age-related and non-communicable diseases, compelling ...
Breaking Medicine Technology:Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 3Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 2Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 3Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 4
... HAYWARD, Calif., Dec. 14, 2010 Anthera Pharmaceuticals, Inc. ... drugs to treat serious diseases associated with abnormal auto-immune ... in the UK, to manufacture the large scale GMP ... peptibody in development for a number of autoimmune diseases. ...
... announces that a new market research report is available ... Global Markets http://www.reportlinker.com/p0341186/Antiemetics-Technologies-and-Global-Markets.html ... billion in 2009.  There was a little setback seen ... economy and competition within brands and generics.  The market ...
Cached Medicine Technology:Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Anthera's Investigational Novel Peptibody Agent 2Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Anthera's Investigational Novel Peptibody Agent 3Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Anthera's Investigational Novel Peptibody Agent 4Reportlinker Adds Antiemetics: Technologies and Global Markets 2Reportlinker Adds Antiemetics: Technologies and Global Markets 3Reportlinker Adds Antiemetics: Technologies and Global Markets 4Reportlinker Adds Antiemetics: Technologies and Global Markets 5Reportlinker Adds Antiemetics: Technologies and Global Markets 6Reportlinker Adds Antiemetics: Technologies and Global Markets 7Reportlinker Adds Antiemetics: Technologies and Global Markets 8Reportlinker Adds Antiemetics: Technologies and Global Markets 9Reportlinker Adds Antiemetics: Technologies and Global Markets 10Reportlinker Adds Antiemetics: Technologies and Global Markets 11Reportlinker Adds Antiemetics: Technologies and Global Markets 12Reportlinker Adds Antiemetics: Technologies and Global Markets 13
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Thermostatically controlled, large capacity surface to quickly evaporate water and solvents from slides and mounting media....
Liquichek Blood Gas Plus CO-Oximeter Control (IL Synthesis Series) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximetry anal...
Medicine Products: